Ticker AGRX – Agile Thrpe – sales, description, marketcap – Tickerday.com

AGRX

Agile Thrpe

–

Index: NASDAQ; Sector: Healthcare; Industry: Biotechnology & Drugs;

Marketcap: 264.51M; Volume: 359.23K; AvgVol 3m: 1.38M; Beta: 1.42;

Cost estimate:

P/E: –; EPS: -0.41; EPS growth quarter/prev quarter: -55.90%;

EPS growth this year: 34.70%; EPS growth past 5 years: 23.20%;

EPS ttm: -0.41;

P/S: ; P/B: 3.33; P/Cashflow: 03.09; P/FCF: ;

Sales: –; Sales growth quarter/prev quarter: ; Sales growth past 5 years: ;

Profitability:

Gross Margin: ; Profit Margin: ; Operating Margin: ;

ROA – return on assets: -39.50%; ROE – return on equity: -46.80%; LT Debt/Equity: 0.20; Total Debt/Equity: 0.00;

Dividend: –; Dividend Yield (%): –;

Insider Ownership: 0.90%; Insider Transactions:1.16%;

Institutional Ownership: 50.80%; Institutional Transactions: 14.79%;

Data update: 07.10.2020.